DE2355204A1 - Pharmazeutische allopurinol-enthaltende zubereitungen und verfahren zu ihrer herstellung - Google Patents

Pharmazeutische allopurinol-enthaltende zubereitungen und verfahren zu ihrer herstellung

Info

Publication number
DE2355204A1
DE2355204A1 DE19732355204 DE2355204A DE2355204A1 DE 2355204 A1 DE2355204 A1 DE 2355204A1 DE 19732355204 DE19732355204 DE 19732355204 DE 2355204 A DE2355204 A DE 2355204A DE 2355204 A1 DE2355204 A1 DE 2355204A1
Authority
DE
Germany
Prior art keywords
allopurinol
tablet
tablet formulation
formulation according
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19732355204
Other languages
German (de)
English (en)
Inventor
David Harden
Henry J Kessler
Allan John Torode
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE2355204A1 publication Critical patent/DE2355204A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
DE19732355204 1972-11-06 1973-11-05 Pharmazeutische allopurinol-enthaltende zubereitungen und verfahren zu ihrer herstellung Pending DE2355204A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5105072A GB1445983A (en) 1972-11-06 1972-11-06 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
DE2355204A1 true DE2355204A1 (de) 1974-05-16

Family

ID=10458450

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732355204 Pending DE2355204A1 (de) 1972-11-06 1973-11-05 Pharmazeutische allopurinol-enthaltende zubereitungen und verfahren zu ihrer herstellung

Country Status (14)

Country Link
JP (1) JPS577127B2 (fr)
AU (1) AU467532B2 (fr)
BE (1) BE806946A (fr)
CA (1) CA975297A (fr)
CH (1) CH583734A5 (fr)
CY (1) CY940A (fr)
DE (1) DE2355204A1 (fr)
FR (1) FR2205309B1 (fr)
GB (1) GB1445983A (fr)
HK (1) HK1278A (fr)
IL (1) IL43562A (fr)
KE (1) KE2807A (fr)
MY (1) MY7800180A (fr)
ZA (1) ZA738489B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2506099A1 (de) * 1974-02-14 1975-08-21 Wellcome Found Pharmazeutische formulierungen zur oralen verabfolgung
US4143129A (en) 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2608045B1 (fr) * 1986-12-12 1990-03-02 Chauvin Laboratoires Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975850A (en) * 1955-08-10 1964-11-18 Wellcome Found Xanthine oxidase inhibitors

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2506099A1 (de) * 1974-02-14 1975-08-21 Wellcome Found Pharmazeutische formulierungen zur oralen verabfolgung
US4143129A (en) 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets

Also Published As

Publication number Publication date
FR2205309B1 (fr) 1976-04-09
IL43562A (en) 1976-08-31
MY7800180A (en) 1978-12-31
CA975297A (en) 1975-09-30
CH583734A5 (fr) 1977-01-14
AU6217773A (en) 1975-05-08
ZA738489B (en) 1975-02-26
IL43562A0 (en) 1974-03-14
HK1278A (en) 1978-01-13
KE2807A (en) 1978-02-17
BE806946A (fr) 1974-05-06
JPS577127B2 (fr) 1982-02-09
CY940A (en) 1978-06-23
AU467532B2 (en) 1975-12-04
FR2205309A1 (fr) 1974-05-31
JPS49133517A (fr) 1974-12-21
GB1445983A (en) 1976-08-11

Similar Documents

Publication Publication Date Title
DE69730834T2 (de) Verfahren zur herstellung von festen oralen dosierungsformen von valsartan
DE69434479T2 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
DE60133538T2 (de) Formulierung und tabletten mit guaifenesin mit verzögerter freisetzung
CH662947A5 (de) Sich schnell aufloesende, pharmazeutische zubereitung sowie verfahren zu ihrer herstellung.
DE69913197T2 (de) Natriumhydrogendivalproat-formulierungen mit gesteuerter freigabe
EP0439030B1 (fr) Formes d'administration orale contenant du pimobendane
DE3510129A1 (de) Lagerstabile, schnellzerfallende pharmazeutische wirkstoff-presslinge
DE2816055A1 (de) Neuer excipient und diesen enthaltende pharmazeutische zusammensetzung
DE4101873C2 (de) Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
DE3431861A1 (de) Pellet-zubereitung
DE2813480A1 (de) Arzneimittel-depotpraeparat vom mehrfacheinheitsdosen-typ
DE2224534A1 (de) Pharmazeutisches Präparat mit langsamer Wirkstoffabgabe
DE1927130A1 (de) Depotarzneimittel in Tablettenform
EP1077703B1 (fr) Formes galeniques orales a liberation reproductible du principe actif de gatifloxacine ou de sels et d'hydrates utilisables au plan pharmaceutique
AT399277B (de) Festes pharmazeutisches piroxicam-präparat und verfahren zu seiner herstellung
DE3232873A1 (de) Pharmazeutisches praeparat
DE2128461A1 (de) Pharmazeutisches Präparat
DE60211183T2 (de) Pharmazeutische zusammensetzung enthaltend lumiracoxib
EP0250648A2 (fr) Préparation pharmaceutique pour la libération retardée de l'ibuprofène
DE60110666T2 (de) Feste Zubereitung enthaltend niedersubstituierte Hydroxypropylcellulose und Herstellungsverfahren
DE1298237B (de) Verfahren zur Herstellung von Tabletten aus therapeutischem gepulvertem Material ohne vorheriges Granulieren
DE3100191C2 (fr)
DE1492253A1 (de) Verfahren zur Herstellung von Tabletten mit protrahierter Wirkung
DE2520978C3 (de) Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten
EP0146863A2 (fr) Formulations orales à effet retard contenant de l'acide acétylsalicylique

Legal Events

Date Code Title Description
OHN Withdrawal